nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP19A1—polycystic ovary syndrome	0.636	1	CbGaD
Etomidate—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0337	0.262	CbGeAlD
Etomidate—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0194	0.151	CbGeAlD
Etomidate—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0152	0.118	CbGeAlD
Etomidate—SLC2A1—embryo—polycystic ovary syndrome	0.0065	0.0505	CbGeAlD
Etomidate—CYP11B2—adrenal cortex—polycystic ovary syndrome	0.00456	0.0355	CbGeAlD
Etomidate—CYP11B1—adrenal cortex—polycystic ovary syndrome	0.00456	0.0355	CbGeAlD
Etomidate—SLC2A1—uterus—polycystic ovary syndrome	0.00438	0.0341	CbGeAlD
Etomidate—SLC2A1—adipose tissue—polycystic ovary syndrome	0.00429	0.0333	CbGeAlD
Etomidate—SLC2A1—adrenal gland—polycystic ovary syndrome	0.00385	0.0299	CbGeAlD
Etomidate—SLC2A1—female gonad—polycystic ovary syndrome	0.00359	0.0279	CbGeAlD
Etomidate—SLC2A1—vagina—polycystic ovary syndrome	0.00356	0.0277	CbGeAlD
Etomidate—SLC2A1—endocrine gland—polycystic ovary syndrome	0.00333	0.0259	CbGeAlD
Etomidate—CYP11B2—adrenal gland—polycystic ovary syndrome	0.00329	0.0256	CbGeAlD
Etomidate—CYP11B1—adrenal gland—polycystic ovary syndrome	0.00329	0.0256	CbGeAlD
Etomidate—CYP11B2—endocrine gland—polycystic ovary syndrome	0.00286	0.0222	CbGeAlD
Etomidate—CYP11B1—endocrine gland—polycystic ovary syndrome	0.00286	0.0222	CbGeAlD
Etomidate—GABRG2—pituitary gland—polycystic ovary syndrome	0.00168	0.0131	CbGeAlD
Etomidate—CYP19A1—endometrium—polycystic ovary syndrome	0.0015	0.0117	CbGeAlD
Etomidate—Ephedrine—ADRA1A—polycystic ovary syndrome	0.00148	0.357	CrCbGaD
Etomidate—CYP19A1—uterus—polycystic ovary syndrome	0.00139	0.0108	CbGeAlD
Etomidate—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00136	0.0105	CbGeAlD
Etomidate—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00122	0.00945	CbGeAlD
Etomidate—CYP19A1—female gonad—polycystic ovary syndrome	0.00113	0.00882	CbGeAlD
Etomidate—Pseudoephedrine—ADRA1A—polycystic ovary syndrome	0.00112	0.27	CrCbGaD
Etomidate—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00105	0.0082	CbGeAlD
Etomidate—Ephedrine—ADRB2—polycystic ovary syndrome	0.00088	0.212	CrCbGaD
Etomidate—Pseudoephedrine—ADRB2—polycystic ovary syndrome	0.000667	0.161	CrCbGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.45e-05	0.000365	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GNRH1—polycystic ovary syndrome	8.36e-05	0.000361	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TH—polycystic ovary syndrome	8.34e-05	0.000361	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	8.3e-05	0.000358	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RACGAP1—polycystic ovary syndrome	8.26e-05	0.000357	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NPB—polycystic ovary syndrome	8.25e-05	0.000357	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	8.22e-05	0.000355	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SRD5A1—polycystic ovary syndrome	8.19e-05	0.000354	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—SLC2A4—polycystic ovary syndrome	8.12e-05	0.000351	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NMNAT3—polycystic ovary syndrome	8.08e-05	0.000349	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HMMR—polycystic ovary syndrome	8.08e-05	0.000349	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	8.05e-05	0.000348	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	8.05e-05	0.000348	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SCT—polycystic ovary syndrome	8.01e-05	0.000346	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	7.89e-05	0.000341	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—STAR—polycystic ovary syndrome	7.81e-05	0.000338	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NCOR1—polycystic ovary syndrome	7.75e-05	0.000335	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.72e-05	0.000334	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HSD3B1—polycystic ovary syndrome	7.71e-05	0.000333	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.71e-05	0.000333	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	7.64e-05	0.00033	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.63e-05	0.00033	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.62e-05	0.000329	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NRG1—polycystic ovary syndrome	7.6e-05	0.000329	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	7.59e-05	0.000328	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	7.59e-05	0.000328	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.53e-05	0.000326	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	7.47e-05	0.000323	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	7.41e-05	0.00032	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	7.39e-05	0.000319	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	7.39e-05	0.000319	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.3e-05	0.000315	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.22e-05	0.000312	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	7.16e-05	0.000309	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	7.15e-05	0.000309	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	7.1e-05	0.000307	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—LHB—polycystic ovary syndrome	7.03e-05	0.000304	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMMR—polycystic ovary syndrome	6.96e-05	0.000301	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—LHCGR—polycystic ovary syndrome	6.89e-05	0.000298	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTGER3—polycystic ovary syndrome	6.89e-05	0.000298	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	6.89e-05	0.000298	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	6.87e-05	0.000297	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HSD3B2—polycystic ovary syndrome	6.87e-05	0.000297	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	6.85e-05	0.000296	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTHFR—polycystic ovary syndrome	6.85e-05	0.000296	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GNAS—polycystic ovary syndrome	6.81e-05	0.000294	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.71e-05	0.00029	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	6.7e-05	0.00029	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKR1C1—polycystic ovary syndrome	6.65e-05	0.000288	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HSD3B1—polycystic ovary syndrome	6.64e-05	0.000287	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.57e-05	0.000284	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IRS2—polycystic ovary syndrome	6.51e-05	0.000281	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NCOR1—polycystic ovary syndrome	6.49e-05	0.00028	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTAFR—polycystic ovary syndrome	6.44e-05	0.000278	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	6.38e-05	0.000276	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.27e-05	0.000271	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	6.26e-05	0.00027	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.22e-05	0.000269	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP1A1—polycystic ovary syndrome	6.15e-05	0.000266	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.15e-05	0.000266	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	6.13e-05	0.000265	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SULT2A1—polycystic ovary syndrome	6.12e-05	0.000265	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	6.1e-05	0.000263	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	6.09e-05	0.000263	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—LHB—polycystic ovary syndrome	6.06e-05	0.000262	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	5.95e-05	0.000257	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—RRM2—polycystic ovary syndrome	5.93e-05	0.000256	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HSD3B2—polycystic ovary syndrome	5.92e-05	0.000256	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	5.84e-05	0.000252	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	5.84e-05	0.000252	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—polycystic ovary syndrome	5.73e-05	0.000248	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKR1C1—polycystic ovary syndrome	5.73e-05	0.000248	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—YAP1—polycystic ovary syndrome	5.72e-05	0.000247	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.72e-05	0.000247	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IRS1—polycystic ovary syndrome	5.69e-05	0.000246	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GHRL—polycystic ovary syndrome	5.64e-05	0.000244	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.62e-05	0.000243	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.62e-05	0.000243	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FLT4—polycystic ovary syndrome	5.58e-05	0.000241	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—FSHR—polycystic ovary syndrome	5.55e-05	0.00024	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE3B—polycystic ovary syndrome	5.54e-05	0.000239	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.53e-05	0.000239	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NAMPT—polycystic ovary syndrome	5.49e-05	0.000237	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.46e-05	0.000236	CbGpPWpGaD
Etomidate—SLC2A1—Disease—INS—polycystic ovary syndrome	5.45e-05	0.000235	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP11A1—polycystic ovary syndrome	5.42e-05	0.000234	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.39e-05	0.000233	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SULT2A1—polycystic ovary syndrome	5.28e-05	0.000228	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT2—polycystic ovary syndrome	5.26e-05	0.000227	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.23e-05	0.000226	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.23e-05	0.000226	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKR1C3—polycystic ovary syndrome	5.12e-05	0.000221	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—RRM2—polycystic ovary syndrome	5.11e-05	0.000221	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	5.08e-05	0.000219	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAT—polycystic ovary syndrome	5.05e-05	0.000218	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP17A1—polycystic ovary syndrome	5.04e-05	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—FSHR—polycystic ovary syndrome	5.04e-05	0.000218	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SERPINE1—polycystic ovary syndrome	5e-05	0.000216	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—YAP1—polycystic ovary syndrome	4.93e-05	0.000213	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.92e-05	0.000212	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	4.9e-05	0.000212	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	4.89e-05	0.000211	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPB—polycystic ovary syndrome	4.88e-05	0.000211	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	4.87e-05	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	4.86e-05	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—LHB—polycystic ovary syndrome	4.83e-05	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—POMC—polycystic ovary syndrome	4.82e-05	0.000208	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.78e-05	0.000207	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	4.78e-05	0.000206	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NAMPT—polycystic ovary syndrome	4.73e-05	0.000205	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	4.72e-05	0.000204	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.71e-05	0.000203	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP11A1—polycystic ovary syndrome	4.67e-05	0.000202	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	4.67e-05	0.000202	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PPARG—polycystic ovary syndrome	4.65e-05	0.000201	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.64e-05	0.000201	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	4.64e-05	0.000201	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	4.62e-05	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	4.61e-05	0.000199	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—POMC—polycystic ovary syndrome	4.59e-05	0.000198	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.57e-05	0.000197	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—INS—polycystic ovary syndrome	4.56e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SCT—polycystic ovary syndrome	4.53e-05	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	4.44e-05	0.000192	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	4.43e-05	0.000191	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKR1C3—polycystic ovary syndrome	4.41e-05	0.000191	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	4.41e-05	0.000191	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	4.39e-05	0.00019	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.39e-05	0.00019	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—LHB—polycystic ovary syndrome	4.39e-05	0.00019	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TH—polycystic ovary syndrome	4.36e-05	0.000189	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP17A1—polycystic ovary syndrome	4.35e-05	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GNAS—polycystic ovary syndrome	4.33e-05	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	4.32e-05	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	4.29e-05	0.000185	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SLC2A4—polycystic ovary syndrome	4.24e-05	0.000183	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.18e-05	0.000181	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SCT—polycystic ovary syndrome	4.11e-05	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.07e-05	0.000176	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.07e-05	0.000176	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.01e-05	0.000173	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP19A1—polycystic ovary syndrome	3.99e-05	0.000172	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	3.95e-05	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.92e-05	0.000169	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GNAS—polycystic ovary syndrome	3.87e-05	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.83e-05	0.000166	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.81e-05	0.000165	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	3.76e-05	0.000163	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TH—polycystic ovary syndrome	3.76e-05	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.72e-05	0.000161	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.7e-05	0.00016	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SLC2A4—polycystic ovary syndrome	3.66e-05	0.000158	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.59e-05	0.000155	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GNAS—polycystic ovary syndrome	3.56e-05	0.000154	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.53e-05	0.000152	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.51e-05	0.000152	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INHBB—polycystic ovary syndrome	3.5e-05	0.000151	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP19A1—polycystic ovary syndrome	3.44e-05	0.000149	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	3.43e-05	0.000148	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NCOR1—polycystic ovary syndrome	3.39e-05	0.000147	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.36e-05	0.000145	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.27e-05	0.000141	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.25e-05	0.00014	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1A1—polycystic ovary syndrome	3.22e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.19e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	3.18e-05	0.000137	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GNAS—polycystic ovary syndrome	3.07e-05	0.000133	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.04e-05	0.000131	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—polycystic ovary syndrome	3e-05	0.00013	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.99e-05	0.000129	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.98e-05	0.000129	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NCOR1—polycystic ovary syndrome	2.92e-05	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.92e-05	0.000126	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	2.9e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.9e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.8e-05	0.000121	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	2.79e-05	0.000121	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1A1—polycystic ovary syndrome	2.77e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.72e-05	0.000118	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	2.68e-05	0.000116	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.67e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FST—polycystic ovary syndrome	2.66e-05	0.000115	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.65e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.64e-05	0.000114	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.63e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.62e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LHB—polycystic ovary syndrome	2.59e-05	0.000112	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—polycystic ovary syndrome	2.58e-05	0.000112	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.53e-05	0.000109	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—polycystic ovary syndrome	2.51e-05	0.000108	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT2—polycystic ovary syndrome	2.51e-05	0.000108	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.5e-05	0.000108	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.46e-05	0.000106	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.45e-05	0.000106	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.45e-05	0.000106	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—polycystic ovary syndrome	2.43e-05	0.000105	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SCT—polycystic ovary syndrome	2.43e-05	0.000105	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—POMC—polycystic ovary syndrome	2.4e-05	0.000104	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.4e-05	0.000104	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—INS—polycystic ovary syndrome	2.39e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINE1—polycystic ovary syndrome	2.38e-05	0.000103	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—polycystic ovary syndrome	2.38e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.32e-05	0.0001	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.28e-05	9.84e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.26e-05	9.76e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.22e-05	9.61e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TH—polycystic ovary syndrome	2.13e-05	9.21e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.11e-05	9.11e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—polycystic ovary syndrome	2.1e-05	9.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.08e-05	8.98e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.07e-05	8.96e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—polycystic ovary syndrome	2.07e-05	8.93e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INS—polycystic ovary syndrome	2.06e-05	8.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	1.99e-05	8.59e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.89e-05	8.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.86e-05	8.03e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	1.84e-05	7.95e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	1.74e-05	7.52e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.71e-05	7.39e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.71e-05	7.39e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.66e-05	7.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.65e-05	7.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	1.64e-05	7.08e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.63e-05	7.05e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.59e-05	6.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.58e-05	6.85e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.57e-05	6.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.51e-05	6.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.5e-05	6.47e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	1.49e-05	6.45e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.46e-05	6.33e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.44e-05	6.22e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.42e-05	6.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.31e-05	5.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.25e-05	5.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.23e-05	5.31e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.19e-05	5.13e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.17e-05	5.06e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.16e-05	5.03e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.05e-05	4.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.03e-05	4.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	9.18e-06	3.97e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	8.84e-06	3.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	8.79e-06	3.8e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	8.51e-06	3.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.5e-06	3.67e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.08e-06	3.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.5e-06	2.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.56e-06	2.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	3.84e-06	1.66e-05	CbGpPWpGaD
